Back to top
more

ShockWave Medical (SWAV)

(Delayed Data from NSDQ)

$330.13 USD

330.13
1,025,697

-0.75 (-0.23%)

Updated May 17, 2024 04:00 PM ET

After-Market: $330.09 -0.04 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (140 out of 249)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Shockwave Medical (SWAV) Misses Q2 Earnings Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of -12.64% and 3.96%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar?

Style Box ETF report for IWO

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Is Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) a Strong ETF Right Now?

Smart Beta ETF report for JSMD

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

Smart Beta ETF report for XHE

Implied Volatility Surging for ShockWave Medical (SWAV) Stock Options

Investors need to pay close attention to ShockWave Medical (SWAV) stock based on the movements in the options market lately.

Is Invesco S&P MidCap 400 Equal Weight ETF (EWMC) a Strong ETF Right Now?

Smart Beta ETF report for EWMC

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?

Style Box ETF report for IWM

ShockWave Medical (SWAV) Hits 52-Week High: Will it Continue?

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Andrew Rocco headshot

3 Healthcare Trends to Ride for Longevity

Because of their longevity, predictability, and stability, healthcare trends can persist for years. The companies covered today are fundamentally and technically robust stocks currently taking advantage of these trends.

Shockwave Medical (SWAV) Launches IVL Catheter in Select Markets

Shockwave Medical's (SWAV) latest commercial availability and the patient enrollment in its study are expected to serve a wider patient pool.

Shockwave Medical (SWAV) Q1 Earnings Top, Revenues Surge Y/Y

Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

Shockwave Medical (SWAV) Beats Q1 Earnings and Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 27.16% and 10.62%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar?

Style Box ETF report for IWO

Andrew Rocco headshot

Healthcare: An Essential Sector (3 Stocks to Buy Ahead of Earnings)

Healthcare stocks are an excellent place to park your money in the current market environment. Due to it's necessity, the sector tends to due well in any economy.

Shockwave Medical (SWAV) Moves 10.6% Higher: Will This Strength Last?

Shockwave Medical (SWAV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Pacific Biosciences (PACB) Stock Jumps 18.7%: Will It Continue to Soar?

Pacific Biosciences (PACB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Is the Options Market Predicting a Spike in Shockwave Medical (SWAV) Stock?

Investors need to pay close attention to Shockwave Medical (SWAV) stock based on the movements in the options market lately.

Shockwave Medical (SWAV) Launches New IVL Catheter in U.S.

Shockwave Medical's (SWAV) latest U.S. launch is expected to serve a wider patient pool.

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.